Reem Hospital today announced the successful completion and database lock for its clinical trial, the TauRx TRx-237-805 study ...
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...
By Dennis Thompson HealthDay ReporterTUESDAY, Jan. 6, 2026 (HealthDay News) — A mail-in blood test accurately detects markers ...
The new self-sampling method, which is done at home and the dry sample sent by post, could make Alzheimer's testing much more ...
A new international study has demonstrated that Alzheimer's disease biomarkers can be accurately detected using simple finger ...
A study conducted in Spain and other European countries refines a method to simplify the early diagnosis of the leading cause ...
A groundbreaking international study has demonstrated that Alzheimer's disease biomarkers can be accurately detected using ...
At home blood tests could soon be used to diagnose dementia, revolutionising dementia care and treatment access.
Scientists have reversed advanced Alzheimer’s in mice by restoring a key brain energy molecule, achieving full cognitive ...
Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on ...
New Financing Supports Disciplined Clinical Execution and Value Creation in Alzheimer's Drug Development - POTOMAC, MARYLAND / ACCESS Newswire / January 5, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ...
Neumora Therapeutics (NMRA) stock jumps as the company posts early-stage trial data for its experimental drug for Alzheimer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback